BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development
German independent research institute BioMed X has started a new research project ‘Advanced Biomarker Detection for Pharma-cological Monitoring in the Brain’ (BDB) in collaboration with Boehringer Ingelheim. The objective of the research group ‘BDB’ is to develop a continuous monitoring biosensor for direct detection of small molecule biomarkers in rodent brain tissue to support the […]
